Listen to a podcast, please open Podcast Republic app. Available on Google Play Store and Apple App Store.
Episode | Date |
---|---|
Podcast: The British start-up taking psychedelic therapy mainstream
|
Oct 16, 2023 |
test
|
Oct 16, 2023 |
What kind of consistency can industry expect from the FDA post pandemic?
|
Jul 22, 2021 |
Chicago emerging as a life science and biopharma hub
|
May 17, 2021 |
Will Biden backed bills boost biosimilars uptake in the US?
|
May 07, 2021 |
Bioproduction bottlenecks increasing due to staff shortages, says report
|
Aug 15, 2017 |
'The sexiness of the ADC world' - CMOs talk antibody-drug hybrids at CPhI
|
Oct 30, 2013 |
Better single-use cross flow techs still needed says GE Healthcare
|
Oct 15, 2013 |
Immunocore CEO: 3rd Big Pharma Eying Unique Cancer Targeting Tech
|
Jul 16, 2013 |
Customers to Save up to 65% as ASI and Chromatan Pen Single-Use Deal
|
Apr 29, 2013 |
ATMI: Single Use Bioreactors on the Up, but US Tails Europe
|
Feb 20, 2013 |
The single-use age has dawned, says ThermoFisher
|
May 20, 2012 |
European CMO market will double in just 6 years, says Frost & Sullivan
|
Mar 15, 2012 |
Acuros in talks with Big Pharma over water-powered delivery pump
|
Mar 13, 2012 |
Unilife launches Autoinfuser range publically
|
Feb 23, 2012 |
EMD Millipore talks integration: of processes; and with owner Merck KGaA
|
Apr 05, 2011 |
OctoPlus, Glycotope, Merck KGaA and SCM Pharma on BioPh 2009
|
Oct 29, 2009 |
Gene therapy to drive viral and biologics market, says SAFC
|
Oct 13, 2009 |
BIO 2009: snapshot of an evolving biotech industry
|
May 21, 2009 |